Bristol-Myers Slashes Outlook As Q4 Profit Misses The Mark

From Bristol-Myers Squibb Co (NYSE:BMY) early Thursday posted mixed fourth quarter earnins reuslts and lowered its 2017 outlook, amid fears of regulators capping drug prices.
NYSE:BMY January 26, 2017 8:09am

Bristol-Myers Collapse Was Predicted By These Technical Patterns

From Corey Rosenbloom: If you’ve ever wondered why we chart momentum and volume along with price, BMY tells us why. On Friday, shares literally collapsed back to the lows, down from the prior swing highs.
NYSE:BMY January 22, 2017 8:12am

Bristol-Myers Squibb Alters Operating Model as Q3 Earnings Top View

BristolMyersSquibb-Co-logoBiotech and pharmaceutical giant Bristol-Myers Squibb Co (NYSE:BMY) this morning posted market-beating Q3 earnings results and announced a restructuring plan it hopes can accelerate the development of new drugs.
NYSE:BMY October 27, 2016 7:56am

Can Bristol-Myers Squibb Co Turn Things Around With Q3 Earnings?

BMY logoFrom Zacks Research: Pharma giant Bristol-Myers Squibb Co (NYSE:BMY) has seen its stock fall precipitiously this year. Will next week's report help the company rebound?
NYSE:BMY October 21, 2016 11:22am

Bristol-Myers Shares Plunge 7% as Lung Cancer Drug Fails Again

Bristol Myers logoDrug giant Bristol-Myers Squibb Co (NYSE:BMY) saw its shares fall up to 7% in early trading today, as news broke that an important immune-based therapy once again failed a lung cancer trial.
NYSE:BMY October 10, 2016 9:05am

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories